Trial Profile
Confirmatory Study of OPC-12759 Ophthalmic Suspension in Dry Eye Patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Rebamipide (Primary) ; Hyaluronic acid
- Indications Dry eyes
- Focus Therapeutic Use
- Sponsors Otsuka Pharmaceutical
- 19 Apr 2014 New trial record